For each 1 ng/ml increment of FABP4 level in serum, the risk of stroke recurrence would be elevated by 12% in unadjusted model (with the OR of 1.12 [95% CI 1.06–1.17], P<0.001) and 8% in adjusted model (1.08 [1.02–1.14], P=0.006) (Table 2). The gene discussed is FABP4; the disease is stroke disorder.